PROSPECTS FOR COMBINATION THERAPY IN TATTOO REMOVAL: AN ANALYSIS OF THE EFFICACY OF PICOSECOND LASER AND THE POTENTIAL ROLE OF IMMUNOMODULATION (LITERATURE REVIEW)
Introduction
In a French nationally representative study (N = 5000, 2017), 17.2% of respondents had tattoos; of these, 14.4% expressed regret about their tattoo, and 17.4% reported attempting to remove at least one tattoo [1]. In another study, 17% of participants reported skin problems at the tattoo site; however, this indicator should not be equated with the intention to remove the tattoo [1]. The most effective tattoo removal methods include excision, various forms of dermabrasion, and laser treatment. Despite the abundance of methods offered in practical medicine for removing tattoo pigment from the dermis, the cosmetic result is often unsatisfactory, especially when the epidermis is destroyed together with pigment particles or when the skin is excised [2, 3].
The excision method is the most invasive and outdated. It involves surgical removal of the skin area with the tattoo followed by closure of the wound edges with a cosmetic suture [4]. This operation is applicable only to relatively small tattoos; otherwise, a deficiency of skin flaps occurs, making it difficult to close the postoperative defect. Dermabrasion can be performed using abrasive materials, sprayed aluminum oxide crystals, or cryodestructive techniques. Chemical peeling is performed using various creams, lotions, and gels. However, despite their invasiveness and unsatisfactory cosmetic results, these approaches often remain ineffective.
Today, laser destruction of pigment, based on the principle of selective photothermolysis, is recognized as the "gold standard" of tattoo removal [5]. To increase the effectiveness of laser exposure, various methods have been proposed to reduce the barrier function of the epidermis, allowing for an increase in the depth of radiation penetration into biological tissues [2, 6]. In addition, optimization of the optical and physical parameters of selective photothermolysis and the characteristics of Q-switched laser radiation is considered an important reserve for improving clinical results [3, 7].
Traditional nanosecond laser systems require 8–15 sessions, which is associated with long treatment, pronounced pain, and high economic costs. Moreover, they often demonstrate low effectiveness against "cold" shades (green, blue, yellow) due to the absorption spectra of these pigments [8, 9].
The emergence of picosecond lasers generating pulses with a duration of less than one nanosecond has opened new prospects due to the dominance of the photoacoustic (mechanical) mechanism of fragmentation over the thermal one [10, 11]. In tattoo removal, picosecond lasers have demonstrated higher clearance efficacy in a number of comparative studies and have expanded the possibilities of treating previously difficult-to-remove multicolored tattoos; however, data on the reduction in the required number of sessions remain heterogeneous [12, 13].
Objective of the study.Based on an analysis of data from 2016–2026, to evaluate the mechanisms of action of picosecond laser, microneedling, and immunomodulators, as well as to analyze the risks of their combined use in tattoo removal.
1. Materials and methods
For the preparation of this review, a literature search was conducted in international (PubMed, Scopus) and domestic (eLibrary) databases. The search depth was from January 2016 to September 2026. An exception was made for fundamental works and patents published before 2016 that are of key importance for understanding the mechanisms of action of the studied methods (No. 22, 23). Inclusion criteria: original research articles, systematic reviews and meta-analyses, experimental studies on laboratory animals evaluating the efficacy and safety of the above methods, as well as publications on the optimization of physical parameters of laser exposure and modification of epidermal barrier properties [3, 6, 7]. Exclusion criteria: conference abstracts without full text, publications in journals not peer-reviewed by Scopus/Web of Science, works describing isolated clinical cases without mechanistic analysis (except for cases directly related to combine methods). A total of 27 publications meeting the quality and thematic criteria were selected and analyzed.
2. Results and discussion
2.1. Picosecond lasers: mechanism of action and clinical efficacy
The key difference between picosecond lasers and nanosecond ones lies in the pulse duration: picosecond systems generate pulses in the range of hundreds of picoseconds (usually 250–500 ps, i.e., less than 1 ns), whereas nanosecond lasers operate in the range of 10⁻⁹ s. For example, the picosecond system used by Bäumler et al. (2022) generated pulses with a duration of 300 and 350 ps [14]. This ensures energy delivery to the tissue faster than the thermal relaxation time of pigment particles. Consequently, the dominant destructive factor becomes not heating, but the generation of a shock wave causing micro-ruptures of dye particles (photoacoustic effect) [10, 11]. This mechanism allows effective fragmentation even of those pigments that are resistant to thermal exposure, including green and blue [11, 12]. An important aspect of increasing the effectiveness of laser destruction is preliminary skin preparation. It has been shown that destruction of the surface layer of the epidermis increases the depth of penetration of laser radiation, which can reduce the required number of sessions [2, 6]. In addition, optimization of the optical and physical characteristics of radiation, including the choice of pulse duration and energy parameters, allows achieving the maximum photoacoustic effect with minimal thermal damage to surrounding tissues [3, 7]. In a randomized split-tattoo study (n = 30), after five identical treatment sessions, a 755-nm picosecond alexandrite laser provided satisfactory clearance (VAS ≥ 7) in 73.3% of treated areas versus 23.3% for a nanosecond alexandrite laser (p = 0.0003); complete clearance was achieved in 10% of cases versus 0%, respectively [15]. In a prospective split study by Bäumler et al. (2022), including 23 patients with 30 tattoos, the efficacy of nanosecond and picosecond lasers was compared. No statistically significant superiority of the picosecond laser in terms of clearance degree was obtained; the adverse reaction profile in both groups was comparable [14]. In a systematic review by Gurnani et al. (2022), it is noted that picosecond lasers demonstrate higher efficacy against difficult-to-remove pigments (in particular, green and blue), however, data from different studies are heterogeneous and do not allow an unambiguous conclusion about the reduction in the number of procedures [12]. Efficacy against green pigment is significantly higher, and the risk of scarring is lower [12].
Additional opportunities for improving results may be provided by modification of temperature conditions of exposure: according to Leontiev et al., changes in the light absorption of tattoo pigments depending on temperature can influence the effectiveness of their fragmentation, which should be taken into account when developing clinical protocols [16]. Technical solutions have also been proposed, such as specialized nozzles for tattoo pigment removal, allowing more precise dosing of energy and reducing the risk of damage to surrounding skin [17].
2.2. Microneedling: role in pigment elimination
Microneedling (dermapuncture) involves the creation of controlled micro-injuries to the skin with needles 1–2 mm long. The pathophysiological rationale for its use in combination with laser is based on three mechanisms [18, 19]:
1. Enhanced lymphatic drainage: the formation of microchannels facilitates the outflow of interstitial fluid containing fragmented pigment into the lymphatic system [19].
2. Induction of aseptic inflammation: micro-injuries attract cells of the monocyte-macrophage lineage to the treatment area, which are key effectors of phagocytosis [20]. It should be noted that, according to Baranska et al. (2018), macrophages participate in the capture, release, and re-capture of pigment, ensuring tattoo stability; therefore, enhanced phagocytosis alone does not guarantee accelerated elimination [20].
3. Stimulation of reparative processes: activation of fibroblasts and neocollagenesis contribute to smoother healing without rough scarring [18].
Microneedling is considered an auxiliary method theoretically capable of improving the elimination of fragmented pigment through the creation of microchannels, enhanced lymphatic drainage, and attraction of macrophages to the treatment area [18, 19]. However, clinical data confirming a significant acceleration of pigment removal when combined with laser are currently limited. In the only available clinical observation by Webber et al. (2017) [21], no visible difference was found between areas treated with Q-switched laser alone and in combination with microneedling. However, the introduction of this technique into widespread practice requires precise control of invasion depth. Errors in setting microneedle parameters create a risk of iatrogenic pigment migration into the reticular dermis, which significantly lengthens the time of its subsequent elimination.
It should be noted that the combination of microneedling with laser exposure can be considered as one of the ways to reduce the barrier function of the epidermis, which, as shown in studies by Mukhin and Leontiev, increases the penetration of laser radiation and potentially enhances the effectiveness of pigment destruction [2, 6]. However, this same effect requires careful dosing to avoid excessive damage to the basal layer and undesirable dissemination of particles.
2.3. Immunomodulators as a means of activating phagocytosis
The most studied immunomodulator in the context of tattoo removal is imiquimod, an agonist of Toll-like receptor 7, stimulating the functional activity of macrophages and dendritic cells. However, clinical data are contradictory. In a randomized double-blind controlled study by Ricotti et al. (2007) [22], 19 of 20 participants completed the study; no significant advantage of imiquimod in tattoo lightening was obtained (3.2 versus 2.9; differences statistically insignificant), while the frequency of adverse reactions was higher in the imiquimod group.
In a guinea pig model, combined use of laser and topical imiquimod provided a more pronounced reduction in pigment compared with isolated laser (p=0.012 by clinical assessment; p=0.047 by histological assessment), but was accompanied by increased inflammation and fibrosis (p=0.002) [23]. In a randomized double-blind study in humans (n=19), no significant advantage of imiquimod in tattoo removal efficacy was obtained, and the frequency of adverse reactions requiring regimen correction reached 60% [22]. Thus, the clinical value of imiquimod as an adjuvant to laser tattoo removal remains uncertain, and the benefit/risk ratio requires further study.
However, direct extrapolation of these results into clinical practice is associated with certain risks. Intensive induction of the cytokine response through transdermal channels created by microneedles may provoke unpredictable systemic effects and excessive local inflammatory reactions. Moreover, typical side effects of imiquimod — from pronounced erythema to erosive-ulcerative lesions — significantly reduce patient adherence and limit the cosmetic applicability of the drug within combined protocols.
Tuftsin and Immunofan are considered as alternative agents. Although tuftsin demonstrates a pronounced ability to enhance the phagocytic index of macrophages in vitro [24], studies confirming a similar effect in vivo in the context of dermal depigmentation are practically absent. Regarding Immunofan, convincing evidence of its influence on the kinetics of dye elimination in available sources is also not presented. Thus, the expediency of including these compounds in therapeutic regimens remains debatable and requires verification in randomized clinical trials.
It is worth noting that the optimization of laser technology for tattoo pigment removal, proposed by Leontiev, includes not only the selection of radiation parameters but also consideration of individual characteristics of pigment composition, which may influence the choice of concomitant immunomodulatory therapy [16]. Patent developments in this field also indicate the possibility of combining physical and pharmacological methods to achieve a synergistic effect [17].
2.4. Safety issues: toxic metabolites and lymphogenic dissemination
During laser fragmentation, the pigment does not disappear but turns into smaller particles whose chemical structure may change. A study by Bauer et al. (2025) using chromatography-mass spectrometry showed that irradiation of green copper-based pigment with a femtosecond laser leads to the formation of compounds such as benzonitrile and phthalimide, which possess potential cytotoxicity [25]. In a systematic review by Fraser et al. (2022), data on the products of photolytic and metabolic degradation of tattoo pigments were summarized. Among the identified compounds are aromatic amines and nitroso compounds, which confirms the complexity and multicomponent nature of pigment degradation processes [26]. Moreover, pigment particles and their degradation products can leave the skin and accumulate in regional lymph nodes. Schreiver et al. (2017), using synchrotron X-ray fluorescence, analyzed postmortem samples of skin and regional lymph nodes of tattooed donors and confirmed that tattoo pigments (including organic pigments, heavy metals, and titanium dioxide) migrate from the skin and are long-term deposited in lymph nodes [27]. This study provided direct analytical evidence of lymphogenic pigment migration, however, its design did not include laser treatment, so it does not allow judging whether laser removal alters this process or its severity. The long-term consequences of such accumulation for the immune system and the body as a whole are currently unknown and require further study [27].
This creates a serious ethical dilemma: by accelerating the elimination of pigment from the skin, we potentially increase the burden on the lymphatic system, which casts doubt on the safety of accelerating these processes without careful monitoring. This problem becomes especially relevant when using methods that reduce the barrier function of the epidermis (e.g., microneedling or chemical destruction of surface layers), which can contribute not only to the penetration of laser radiation but also to the migration of fragmented pigment into the deep dermis and lymphatic system [2, 6].
From a practical standpoint, the choice of optimal laser technology should take into account not only the effectiveness of destruction but also the safety of the resulting metabolites. Studies on optimizing the optical and physical characteristics of radiation [3, 7] and taking into account the temperature dependence of pigment light absorption [16] may help reduce the formation of the most toxic degradation products by selecting gentler irradiation modes. However, systematic studies in this direction are still few.
3. Discussion and limitations of the review
Summarizing the available data allows us to state the presence of a substantial pathophysiological basis for the introduction of multimodal strategies in dermatocosmetology. The synergy of photoacoustic pigment destruction by picosecond laser, creation of transcutaneous channels for drainage and chemoattraction of macrophages using microneedles, and pharmacological stimulation of phagocytosis appears to be a logically complete therapeutic scheme. Nevertheless, the transition from experimental models to real clinical
practice is hindered by a number of unresolved issues.
During this review, the following critical limitations were identified:
1. Lack of standardized protocols: heterogeneity of technical parameters of laser systems, variability of microneedle invasion depth, and absence of clear regimens for immunomodulator use impede adequate meta-analysis and comparison of results between different research groups. Even when using well-studied approaches, such as optimization of optical and physical characteristics of radiation [3, 7] or the use of specialized nozzles [17], the literature presents heterogeneous data that do not allow forming unified recommendations.
2. Deficiency of safety data: to date, there are practically no studies dedicated to monitoring the systemic biodistribution of fragmented pigment. The risk of iatrogenic dissemination of particles through the lymphatic system and their potential deposition in regional nodes remain outside the focus of most authors. Of particular concern is the combination of laser exposure with methods that reduce the barrier function of the epidermis [2, 6], which may unintentionally enhance pigment migration.
3. Heterogeneity of pigments: variability in the composition of tattoo inks and the absence of standardized labeling complicate the prediction of pigment degradation kinetics and assessment of the toxicity of formed metabolites. As shown in the works of Leontiev et al., the temperature dependence of light absorption differs significantly among different pigments [16], which requires individual selection of laser parameters for each type of dye.
4. Ethical limitations: the use of potent immunotropic drugs (in particular, imiquimod) for aesthetic purposes requires strict verification of the expected benefit/risk ratio regarding the development of systemic side effects. Even with technical optimization of laser exposure [16] and the use of auxiliary pharmacological agents, the safety issue remains open.
5. Insufficiency of long-term observation: almost all available studies, including works on optimization of laser technology [3, 7, 15], evaluate only short-term and medium-term results. Data on long-term consequences (after 5–10 years and more) are absent, which does not allow drawing conclusions about the carcinogenic or immunotoxic potential of pigment particles accumulating in lymph nodes.
Conclusion
1. The advantage of picosecond laser systems is due to the dominance of the photoacoustic mechanism of destruction, providing more effective fragmentation of pigments of various color spectra. However, data on the reduction in the number of sessions compared with nanosecond lasers remain heterogeneous. Additional reserves for increasing effectiveness are associated with optimization of optical and physical characteristics of radiation and preliminary skin preparation.
2. Microneedling therapy serves as an auxiliary method potentiating the lymphatic drainage function of the dermis and initiating local accumulation of antigen-presenting cells, which theoretically optimizes the clearance of foreign particles.
3. Despite the experimentally confirmed ability of imiquimod to enhance the phagocytic index of macrophages, its widespread introduction is limited by the high risk of systemic reactions and pronounced local irritating effects. The evidence base for the use of other modulators (tuftsin, Immunofan) in the context of tattoo removal is currently fragmentary or speculative.
4. One of the most acute problems remains the insufficient study of the systemic toxicology of pigment degradation products and the consequences of their accumulation in lymphatic system structures. Even when using technically advanced laser systems, the issue of biological safety of fragmented particles requires additional research.
5. Premature introduction of combined protocols into clinical practice without obtaining convincing data on long-term safety appears unjustified. Further research directions should focus on toxicological monitoring and morphological assessment of the state of lymphoid organs, as well as on the development of standardized approaches to optimizing laser exposure parameters taking into account individual characteristics of pigment composition and the patient's skin condition.
Conflict of Interest
Funding
Bibliographic Reference
URL: https://world-science.ru/en/article/view?id=34430 (accessed: 18/11/2026).
DOI: https://doi.org/10.17513/ejnh.34430
